Metraipolis › archive › dc_b5f79cbb24ae
Lactulose Versus Rifaximin Monotherapy for Hepatic Encephalopathy Prevention: A Prospective Comparative Study in Patients With Cirrhosis — Europe PMC PMID:41163639
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41163639
- DOI
- 10.7759/cureus.95519
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T00:58:20.704Z
- SHA-256 of the archived text
f30fc65626648567e9dc6e1f23427c03e83a3ef76a880945ab50106bdfdff6b7- Stable URL of this page
https://metraipolis.com/documento/dc_b5f79cbb24ae
How to cite
Lactulose Versus Rifaximin Monotherapy for Hepatic Encephalopathy Prevention: A Prospective Comparative Study in Patients With Cirrhosis — Europe PMC PMID:41163639 — Europe PMC (en), https://europepmc.org/article/MED/41163639 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b5f79cbb24ae (Metraipolis archive dc_b5f79cbb24ae, sha256 f30fc65626648567e9dc6e1f23427c03e83a3ef76a880945ab50106bdfdff6b7)
BibTeX
@misc{dcb5f79cbb24ae,
title = {Lactulose Versus Rifaximin Monotherapy for Hepatic Encephalopathy Prevention: A Prospective Comparative Study in Patients With Cirrhosis — Europe PMC PMID:41163639},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41163639},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b5f79cbb24ae; sha256 f30fc65626648567e9dc6e1f23427c03e83a3ef76a880945ab50106bdfdff6b7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41163639. Agents can read the archived copy with the MCP tool read_document.